Acta Med. 2002, 45: 93-97

https://doi.org/10.14712/18059694.2019.62

Comparison of Enoximone, Amrinone, or Levosimendan Enriched St. Thomas’ Hospital Cardioplegic Solutions Used for Myocardial Preservation in Isolated Guinea Pig Hearts

Cengiz Köksala, Öner Süzerb, A Kürsat Bozkurtc, Sebahat Köseoğlud

aSureyyapasa Thoracic and Cardiovascular Disease Hospital, Department of Cardiovascular Surgery, Istanbul, Turkey
bIstanbul University, Cerrahpasa Faculty of Medicine, Department of Pharmacology, Istanbul, Turkey
cIstanbul University, Cerrahpasa Faculty of Medicine, Department of Thoracic and Cardiovascular Surgery, Istanbul, Turkey
dExperimental Medical Research Center, Istanbul, Turkey

Received February 1, 2002
Accepted May 1, 2002

References

1. Chang-Chun C, Matsuda H, Sawa Y et al. Effect of a cyclic adenosine monophosphate phosphodiesterase inhibitor, DN-9693, on myocardial reperfusion injury. Ann Thorac Surg 1991; 52(3):495-9. <https://doi.org/10.1016/0003-4975(91)90911-9>
2. Doyle AR, Dhir AK, Moors AH, Latimer RD. Treatment of perioperative low cardiac output syndrome. Ann Thorac Surg 1995; 59(suppl 2):3-14. <https://doi.org/10.1016/0003-4975(94)00916-U>
3. Honerjager P. Pharmacology of bipyridine phosphodiesterase III inhibitors. Am Heart J 1991;121(part 2); 1939-1944. <https://doi.org/10.1016/0002-8703(91)90828-6>
4. Katsung BG, Parmley WW. Cardiac glycosides & other drugs used in congestive heart failure. In: Katzung BG, Parmley WW (ed). Basic and Clinical Pharmacology. Lange, 5th edition. 1996;197-215.
5. Komai H, Yamamoto F, Tanaka K et al. Harmful effects of inotropic agents on myocardial protection. Ann Thorac Surg 1991; 52(4):927-33. <https://doi.org/10.1016/0003-4975(91)91257-V>
6. Kristof E, Szigeti G, Papp Z et al. The effects of levosimendan on the left ventricular function and protein phosphorylation in post-ischemic guinea pig hearts. Basic Res Cardiol 1999; 94(4):223-30. <https://doi.org/10.1007/s003950050146>
7. Lehtonen LA. Levosimendan: a parenteral calcium-sensitizing drug with additional vasodilatory properties. Expert Opin Investig Drugs 2001; 10(5):955-70. <https://doi.org/10.1517/13543784.10.5.955>
8. Lowes BD, Higginbotham M, Petrovich L et al. Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group. J Am Coll Cardiol 2000; 36(2):501-8. <https://doi.org/10.1016/S0735-1097(00)00759-2>
9. Mikawa K, Akamatsu H, Nishina K et al. The effect of phosphodiesterase III inhibitors on human neutrophil function. Crit Care Med 2000; 28(4):1001-5. <https://doi.org/10.1097/00003246-200004000-00015>
10. Mitrovic V, Strasser R, Berwing K, Thormann J, Schlepper M. Acute effects of enoximone after intracoronary administration on hemodynamics, myocardial perfusion and regional wall motion. Z Kardiol 1996; 85(11):856-67.
11. Nijhawan N, Nicolosi AC, Montgomery MW, Aggarwal A, Pagel PS, Warltier DC. Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial. J Cardiovasc Pharmacol 1999; 34(2):219-28 <https://doi.org/10.1097/00005344-199908000-00007>
12. Rechtman MP, Van der Zypp A, Majewski H. Amrinone reduces ischaemia-reperfusion injury in rat heart. Eur J Pharmacol 2000; 402(3):255-62. <https://doi.org/10.1016/S0014-2999(00)00443-X>
13. Saltman AE, Gaudette GR, Levitsky S, Krukenkamp IB. Amrinone preconditioning in the isolated perfused rabbit heart. Ann Thorac Surg 2000; 70(2):609-13. <https://doi.org/10.1016/S0003-4975(00)01554-X>
14. Shimada Y, Yamamoto F, Yamamoto H, Newling R. Is the use of catecholamine before ischemic arrest safe? Effect of catecholamine on rat heart ischemia/reperfusion injury. Jpn J Thorac Cardiovasc Surg 1999; 47(7):299-312. <https://doi.org/10.1007/BF03218016>
15. Sunderdiek U, Korbmacher B, Gams E, Schipke JD. Myocardial efficiency in stunned myocardium. Comparison of Ca (2+)-sensitization and PDE III-inhibition on energy consumption. Eur J Cardiothorac Surg 2000; 18(1):83-9. <https://doi.org/10.1016/S1010-7940(00)00413-9>
16. Süzer Ö, Bozkurt AK, Süzer A, Aykac Z, Barlas A. Izole kobay kalplerinde iskemik arrest sonrası levosimendan ve amrinonun inotropik etkilerinin karşılaştınlması. Göğüs Kalp Damar Cerrahisi Dergisi 1996; 4:4-8.
17. Süzer Ö, Bozkurt AK, Süzer A, Aykaç Z, Barlas A. Levosimendan is a more potent inotropic agent than amrinone after ischemia in isolated perfused guinea pig hearts. Br J Anaest 1996; 76(suppl 1):A9.
18. Du Toit EF, Muller CA, McCarthy J, Opie LH. Levosimendan: effects of a calcium sensitizer on function and arrhythmia’s and cyclic nucleotide levels during ischemia/ reperfusion in the Langendorff-perfused guinea pig heart. J Pharmacol Exp Ther 1999; 290(2):505-14.
19. Wang Y, Sunamori M, Suzuki A. Effect of phosphodiesterase III-inhibitor (E-1020) adjunct to Bretschneider’s HTK cardioplegic solution on myocardial preservation in rabbit heart. Thorac Cardiovasc Surg 1996; 44(4):167-72. <https://doi.org/10.1055/s-2007-1012010>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive